US · Healthcare · Medical Instruments & Supplies
EPS came in at -0.04 against a street estimate of 0.14 — a miss of 128.6%.
Analysts rate Azenta Inc a hold (2 buy, 5 hold, 0 sell out of 7) with an average price target of $27.80.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.59% |
| Politan Capital Management LP | 10.03% |
| Vanguard Portfolio Management, LLC | 5.32% |
| Dimensional Fund Advisors, Inc. | 4.47% |
| Vanguard Capital Management, LLC | 3.97% |
| Massachusetts Financial Services Company | 3.88% |
| State Street Corp | 3.82% |
| Allspring Global Investments Holdings, LLC | 3.50% |
| Document | Date |
|---|---|
| Material agreement · Q3 2026 | 2026-07-08 |
| Quarterly report · Q1 2026 | 2026-05-08 |
| Results announced · Q2 2026 | 2026-05-05 |
| Board / officer change · Q2 2026 | 2026-04-07 |
| Company announcement · Q1 2026 | 2026-04-02 |
| Quarterly report · Q4 2025 | 2026-02-05 |
| Proxy statement · Q1 2026 | 2025-12-18 |
| Annual report FY2025 | 2025-12-04 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Azenta Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.